Investigators uncover link between eye health, diet and lifespan
June 13th 2022According to investigators, a key reason for the link may lie in circadian “clocks,” the molecular machinery within every cell of every organism, which have evolved to adapt to daily stresses, such as changes in light and temperature caused by the rising and setting of the sun.
Read More
Australian scientists conduct stem cell research unveiling a detailed genetic roadmap of glaucoma
June 12th 2022The research is the result of a national collaboration led by investigators from the Centre for Eye Research Australia at the University of Melbourne and University of Tasmania and the Garvan Institute of Medical Research.
Read More
iSTAR Medical unveils positive results for MINIject across trio of international glaucoma trials
June 11th 2022According to the company, no safety concerns with corneal endothelial health reported across all 3 trials, and the device delivered consistent results up to two-year follow-up in patients across Central and South America, Asia and Europe.
Read More
Study: Investigators make key discovery in AMD
June 6th 2022According to the study by a team of researchers from the University of California Irvine and University of Southern California, treatment with Humanin G reduced protein levels of inflammation markers that become elevated in age-related macular degeneration.
Read More
Health Canada approves faricimab injection for the treatment of wet AMD, DME
June 1st 2022Faricimab is the first treatment for wet AMD and DME in Canada that acts by targeting both VEGF-A and Ang-2, two key drivers of vascular instability that have been associated with vision-threatening retinal conditions.
Read More
Apellis submits NDA to FDA for pegcetacoplan for geographic atrophy
June 1st 2022The company noted that pegcetacoplan, designed to regulate excessive activation of the complement cascade, part of the body’s immune system, which can lead to the onset and progression of many serious diseases, was granted Fast Track designation by the FDA for the treatment of geographic atrophy.
Read More